No Detail Found!

Role of probiotics in inflammatory bowel disease

Author(s)
Darmadi Darmadi Department of Internal Medicine, Faculty of Medicine,Universitas Sumatera Utara,Indonesia
Dina Aprillia Ariestine Department of Internal Medicine, Faculty of Medicine,Universitas Sumatera Utara,Indonesia
Sem Samuel Surja Department of Parasitology, School of Medicine and Health Sciences,Universitas Katolik Jakarta,Indonesia
Abstract
Inflammatory bowel disease (IBD) consists of ulcerative colitis (UC) and Crohn's disease (CD). The global incidence of IBD is increasing recently. Westernization is hypothesized to play role in this phenomenon. Inflammation is the basic etiology of IBD. Genetic and environmental factors are important determinants of IBD. Gastrointestinal microorganism is a component of the environmental factors. Balanced-state microorganism environment is important to maintain normal gastrointestinal function. Dysbiosis, an imbalance in beneficial and pathogenic gastrointestinal microorganism, may elicit inflammation and result in IBD. Dysbiosis causes increased pro-inflammatory activity, decreased anti-inflammatory activity, disrupted gastrointestinal mucosal barrier, and prolonged inflammation. Probioticsare hoped to mend the dysbiosis and alleviate inflammation along with disease course. Studies in human reported that administration of probiotics along with standard therapy for UC gives promising result. In contrast, probiotics have little or no positive effect in CD. Probiotics as adjunctive therapy may be considered in managing patients with UC but not with CD
Publication Details
Page(s) 537-541
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 48, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Ulcerative colitis, probiotics., Crohn’s Disease
0

Citations

0

Downloads

24

Views